BCL2L1 and hepatocellular carcinoma: In hepatocellular carcinoma, let-7b also negatively regulates Bcl-xL expression, potentiating the effect of sorafenib-induced apoptosis by curtailing the anti-apoptotic function of Bcl-xL [30].